BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Price, Quote, News and Overview
NASDAQ:BIOX - Nasdaq - KYG1117K1141 - Common Stock - Currency: USD
BIOX Quote, Performance and Key Statistics
4.55
-0.19 (-4.01%)
The current stock price of BIOX is 4.55 USD. In the past month the price decreased by -33.58%. In the past year, price decreased by -65.27%.
BIOX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CTVA | CORTEVA INC | 24.61 | 43.03B | ||
| NTR | NUTRIEN LTD | 15.03 | 25.83B | ||
| CF | CF INDUSTRIES HOLDINGS INC | 12.12 | 13.56B | ||
| MOS | MOSAIC CO/THE | 11.5 | 8.18B | ||
| ICL | ICL GROUP LTD | 15.43 | 7.96B | ||
| FMC | FMC CORP | 11.02 | 4.78B | ||
| SMG | SCOTTS MIRACLE-GRO CO | 21.59 | 3.47B | ||
| UAN | CVR PARTNERS LP | 13.84 | 842.85M | ||
| IPI | INTREPID POTASH INC | N/A | 335.45M | ||
| AVD | AMERICAN VANGUARD CORP | N/A | 152.01M | ||
| ENFY | ENLIGHTIFY INC | N/A | 18.49M | ||
| NITO | N2OFF INC | N/A | 9.02M |
Related stock screener links
About BIOX
Company Profile
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe. The company went IPO on 2018-03-22. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
Company Info
BIOCERES CROP SOLUTIONS CORP
Ocampo 210 bis, Predio CCT
Rosario SANTA FE 2000 AR
CEO: Federico Trucco
Employees: 389
Company Website: https://biocerescrops.com/
Investor Relations: http://investors.biocerescrops.com/home/default.aspx
Phone: 543414861100
BIOCERES CROP SOLUTIONS CORP / BIOX FAQ
What is the stock price of BIOCERES CROP SOLUTIONS CORP today?
The current stock price of BIOX is 4.55 USD. The price decreased by -4.01% in the last trading session.
What is the ticker symbol for BIOCERES CROP SOLUTIONS CORP stock?
The exchange symbol of BIOCERES CROP SOLUTIONS CORP is BIOX and it is listed on the Nasdaq exchange.
On which exchange is BIOX stock listed?
BIOX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BIOCERES CROP SOLUTIONS CORP stock?
10 analysts have analysed BIOX and the average price target is 10.58 USD. This implies a price increase of 132.58% is expected in the next year compared to the current price of 4.55. Check the BIOCERES CROP SOLUTIONS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOCERES CROP SOLUTIONS CORP worth?
BIOCERES CROP SOLUTIONS CORP (BIOX) has a market capitalization of 285.33M USD. This makes BIOX a Micro Cap stock.
How many employees does BIOCERES CROP SOLUTIONS CORP have?
BIOCERES CROP SOLUTIONS CORP (BIOX) currently has 389 employees.
What are the support and resistance levels for BIOCERES CROP SOLUTIONS CORP (BIOX) stock?
BIOCERES CROP SOLUTIONS CORP (BIOX) has a resistance level at 6.56. Check the full technical report for a detailed analysis of BIOX support and resistance levels.
Is BIOCERES CROP SOLUTIONS CORP (BIOX) expected to grow?
The Revenue of BIOCERES CROP SOLUTIONS CORP (BIOX) is expected to decline by -19.62% in the next year. Check the estimates tab for more information on the BIOX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIOCERES CROP SOLUTIONS CORP (BIOX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BIOX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BIOX, evaluating the profitability, health, valuation and growth aspects
- BIOCERES CROP SOLUTIONS CORP (BIOX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOCERES CROP SOLUTIONS CORP (BIOX) Sales and EPS estimates to see what analysts future expectations are.
- BIOCERES CROP SOLUTIONS CORP (BIOX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOCERES CROP SOLUTIONS CORP (BIOX) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Chart to make your own analysis
- BIOCERES CROP SOLUTIONS CORP (BIOX) Latest news and press-releases to stay up to date.
Does BIOCERES CROP SOLUTIONS CORP (BIOX) stock pay dividends?
BIOX does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIOCERES CROP SOLUTIONS CORP (BIOX)?
The PE ratio for BIOCERES CROP SOLUTIONS CORP (BIOX) is 151.67. This is based on the reported non-GAAP earnings per share of 0.03 and the current share price of 4.55 USD. Check the full fundamental report for a full analysis of the valuation metrics for BIOX.
What is the Short Interest ratio of BIOCERES CROP SOLUTIONS CORP (BIOX) stock?
The outstanding short interest for BIOCERES CROP SOLUTIONS CORP (BIOX) is 2.07% of its float. Check the ownership tab for more information on the BIOX short interest.
BIOX Technical Analysis
BIOX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BIOX. BIOX may be in some trouble as it scores bad on both profitability and health.
BIOX Financial Highlights
Over the last trailing twelve months BIOX reported a non-GAAP Earnings per Share(EPS) of 0.03. The EPS decreased by -91.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.33% | ||
| ROA | 0.18% | ||
| ROE | 0.47% | ||
| Debt/Equity | 0.47 |
BIOX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to BIOX. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -284.41% and a revenue growth -19.62% for BIOX